These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2967472

  • 21. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM, Penner JD, Minutella LM.
    Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
    [Abstract] [Full Text] [Related]

  • 22. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
    Larsen FG, Jakobsen P, Knudsen J, Weismann K, Kragballe K, Nielsen-Kudsk F.
    J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
    [Abstract] [Full Text] [Related]

  • 23. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A, Martín M, Geiger JM, Marrón JM.
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [Abstract] [Full Text] [Related]

  • 24. Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670, etretin).
    Brindley CJ.
    Dermatologica; 1989 Nov; 178(2):79-87. PubMed ID: 2522404
    [Abstract] [Full Text] [Related]

  • 25. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J, Geiger JM.
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [Abstract] [Full Text] [Related]

  • 26. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J, Paravicini U.
    Arch Dermatol Res; 1982 Jul; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract] [Full Text] [Related]

  • 27. Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.
    Ward A, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1983 Jul; 26(1):9-43. PubMed ID: 6224672
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ, Blouin RA.
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [Abstract] [Full Text] [Related]

  • 29. The pharmacokinetics of etretinate and its metabolites in the dog.
    Thongnopnua P, Massarella JW, Zimmerman CL.
    Drug Metab Dispos; 1989 Apr; 17(5):473-80. PubMed ID: 2573489
    [Abstract] [Full Text] [Related]

  • 30. Pustulosis palmo-plantaris. Clinical and histological changes during etretin (acitretin) therapy.
    Schröder K, Zaun H, Holzmann H, Altmeyer P, el-Gammal S.
    Acta Derm Venereol Suppl (Stockh); 1989 Apr; 146():111-6. PubMed ID: 2532841
    [Abstract] [Full Text] [Related]

  • 31. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H, Orfanos CE.
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [Abstract] [Full Text] [Related]

  • 32. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
    Lassus A, Geiger JM.
    Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
    [Abstract] [Full Text] [Related]

  • 33. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
    Jakobsen P, Larsen FG, Larsen CG.
    J Chromatogr; 1987 Apr 10; 415(2):413-8. PubMed ID: 2953748
    [No Abstract] [Full Text] [Related]

  • 34. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR, McNamara PJ.
    Drug Metab Dispos; 1989 Apr 10; 17(6):646-51. PubMed ID: 2575501
    [Abstract] [Full Text] [Related]

  • 35. Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
    Larsen FG, Nielsen-Kudsk F, Jakobsen P, Schrøder H, Kragballe K.
    J Clin Pharmacol; 1990 Sep 10; 30(9):802-7. PubMed ID: 2277127
    [Abstract] [Full Text] [Related]

  • 36. Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in-vitro differentiation of leukemic cells.
    Chomienne C, Balitrand N, Abita JP.
    Leuk Res; 1986 Sep 10; 10(9):1079-81. PubMed ID: 2945054
    [Abstract] [Full Text] [Related]

  • 37. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
    Vahlquist C, Selinus I, Vessby B.
    Acta Derm Venereol; 1988 Sep 10; 68(4):300-5. PubMed ID: 2459874
    [Abstract] [Full Text] [Related]

  • 38. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
    Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, Frenk E, Guilhou JJ, Grosshans E, Mérot Y.
    Dermatologica; 1988 Sep 10; 177(4):218-24. PubMed ID: 2976000
    [Abstract] [Full Text] [Related]

  • 39. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR, McNamara PJ.
    Drug Metab Dispos; 1989 Sep 10; 17(6):652-5. PubMed ID: 2575502
    [Abstract] [Full Text] [Related]

  • 40. Retinoids in psoriasis and disorders of keratinization.
    Fritsch PO.
    J Am Acad Dermatol; 1992 Dec 10; 27(6 Pt 2):S8-14. PubMed ID: 1460124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.